Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Operating Expenses | 1,222 | 1,181 | 1,203 | 1,102 | 1,211 |
| Operating Income | -1,222 | -1,181 | -1,203 | -1,102 | -1,211 |
| Interest Expense | 453 | 0 | 469 | 463 | 410 |
| Other Income | 95 | -489 | 1 | 1 | 6 |
| Pre-tax Income | -1,580 | -1,670 | -1,671 | -1,564 | -1,615 |
| Net Income Continuous | -1,580 | -1,670 | -1,671 | -1,564 | -1,615 |
| Net Income | $-1,580 | $-1,670 | $-1,671 | $-1,564 | $-1,615 |
| EBITDA(a) | $-1,219 | $-1,178 | $-1,199 | $-1,099 | $-1,147 |